Introductory Chapter: Current Perspective of COVID-19 Drugs-Reference-Cited by-同舟云学术

Introductory Chapter: Current Perspective of COVID-19 Drugs

Published:2022-12-07 Issue: Volume: Page:
ISSN:
Container-title:COVID-19 Drug Development - Recent Advances, New Perspectives and Applications
language:
Short-container-title:

Author:

Aditya Parikesit Arli,Nurdiansyah Rizky

Abstract

Publisher

IntechOpen

Link

http://www.intechopen.com/download/pdf/82216

Reference84 articles.

1. Malin JJ, Suárez I, Priesner V, Fätkenheuer G, Rybniker J. Remdesivir against COVID-19 and other viral diseases. Clinical Microbiology Reviews. 2021;34(1):1-21. DOI: 10.1128/CMR.00162-20

2. Eastman RT et al. Remdesivir: A review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS Central Science. 2020;6(5):672. DOI: 10.1021/ACSCENTSCI.0C00489

3. Parikesit AA, Nurdiansyah R. Drug repurposing option for COVID-19 with structural bioinformatics of chemical interactions approach. Cermin Dunia Kedokteran. 2020;47(3):222-226. DOI: 10.5281/zenodo.4460736

4. Shannon A et al. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites. Antiviral Research. 2020;178:104793. DOI: 10.1016/j.antiviral.2020.104793

5. Arba M, Wahyudi ST, Brunt DJ, Paradis N, Wu C. Mechanistic insight on the remdesivir binding to RNA-dependent RNA polymerase (RdRp) of SARS-cov-2. Computers in Biology and Medicine. 2021;129:104156. DOI: 10.1016/j.compbiomed.2020.104156

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Simulation of Coffee Beans’ Natural Products as Lead Compounds for Stroke Remedy;Engineering Headway;2024-04-16

2. Introductory Chapter: Current Landscape of Animal and Human Virus Treatments;Infectious Diseases;2023-12-20